文献速递慢性静脉疾病

同期主干与穿通静脉手术的系统综述与Meta分析

A systematic review and meta-analysis of concomitant truncal and perforator surgery.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2023-02-02

本系统综述与Meta分析检索MEDLINE、Embase和Cochrane数据库(2022年3月),纳入7项研究共872条肢体,比较同期浅静脉加穿通静脉手术与标准治疗。结果显示两组溃疡愈合率相似,但同期组溃疡复发率显著更低(3.7% vs 44%),随访超声识别的穿通静脉总数也显著更少。作者认为同期治疗可考虑用于预防复发而非促进愈合,但纳入研究存在偏倚且随访较短。

要点

  • 同期主干加穿通静脉手术与标准治疗的溃疡愈合率相似(RR 1.07,95%CI 0.96-1.19,P=0.23)。
  • 同期组溃疡复发率显著低于标准治疗组(3.7% vs 44%,RR 0.21,95%CI 0.07-0.65,P=0.007)。
  • 作者认为同期治疗可考虑用于预防溃疡复发,而非改善溃疡愈合。

核心结论

  • 同期主干与穿通静脉手术在溃疡愈合、安全性和有效性方面与标准治疗相当。
  • Meta分析提示同期治疗可显著降低溃疡复发率,但纳入研究存在偏倚且随访较短。
  • 同期治疗可考虑用于预防复发而非改善溃疡愈合。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase和Cochrane数据库,检索时间为2022年3月。
  • 纳入比较同期浅静脉加穿通静脉手术与标准治疗结局的所有研究。
  • 共纳入7项研究、872条肢体,纳入研究方法学质量合理。
  • 采用随机效应模型进行数据合并。

主要发现

  • 溃疡愈合率两组相似(RR 1.07,95%CI 0.96-1.19,P=0.23)。
  • 两项研究报告两组平均愈合时间(天)无差异(均数差-14.60,95%CI -34.57至5.38,P=0.15;I²=0%;P=0.56)。
  • 同期组溃疡复发率显著低于标准治疗组(3.7% vs 44%,RR 0.21,95%CI 0.07-0.65,P=0.007;I²=43%;P=0.17)。
  • 12个月随访时疾病严重程度两组无差异,加权均数差为-0.88(95%CI -2.05至0.29,P=0.14;I²=84%;P=0.002)。
  • 随访超声识别的穿通静脉总数同期组显著低于标准治疗组(22.4% vs 89%,RR 0.31,95%CI 0.19-0.53,P<0.0001;I²=88%;P=0.0002)。

临床怎么用

  • 作者认为同期治疗可考虑用于预防溃疡复发而非改善溃疡愈合。

局限性

  • 纳入研究存在一些偏倚。
  • 纳入研究随访较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Incompetent perforator veins are encountered frequently during ultrasound assessment of the venous system in chronic venous disease. Some studies have shown that concomitant treatment of truncal and perforator incompetence improves ulcer healing, yet a Cochrane review was unable to determine the potential benefits of perforator surgery in venous ulcer management due to poor quality evidence. This study aims to establish the exact role of concomitant treatment in patients with chronic venous disease. METHODS: A search of online databases including MEDLINE, Embase, and Cochrane was performed in March 2022. All studies comparing the outcomes of concomitant superficial venous plus perforator surgery with standard therapy were included. Variables assessed included ulcer healing, time to healing, and ulcer recurrence. Disease severity and quality of life, vein occlusion rates, number of incompetent perforator veins on duplex ultrasound post treatment, and reintervention and complication rates were also analyzed. Data were pooled using a random effects model. RESULTS: Seven studies (872 limbs) were included for analysis. Included studies were of reasonable methodological quality. Ulcer healing rates were similar in each group (relative risk [RR], 1.07; 95% confidence interval [CI] 0.96-1.19; P = .23). Two studies reported no difference in mean time (days) to ulcer healing between groups (mean difference, -14.60; 95% CI, -34.57 to 5.38; P = .15; I2 = 0%; P = .56). Ulcer recurrence was significantly lower in the concomitant group (3.7% vs 44%) (RR, 0.21; 95% CI, 0.07- 0.65; P = .007; I2 = 43%; P = .17). Overall, there was no difference in disease severity measured at 12-month follow-up, with a weighted mean difference between groups of -0.88 (95% CI, -2.05 to 0.29; P = .14; I2 = 84%; P = .002). Quality of life was reported in only one study. The total number of perforator veins identified at follow-up duplex ultrasound was significantly lower in the concomitant group (22.4% vs 89%) compared with standard therapy (RR, 0.31; 95% CI, 0.19-0.53; P < .0001; I2 = 88%; P = .0002). There was no difference between groups for occlusion rates of treated great saphenous vein or incompetent perforators (RR, 2.22; 95% CI, 0.10-49.74; P = .61). Reported minor (RR, 0.98; 95% CI, 0.63-1.52; P = .92) and thrombotic complications (RR, 2.04; 95% CI, 0.59-6.99; P = .26) were similar between groups. CONCLUSIONS: Concomitant truncal and perforator surgery is comparable to standard therapy in terms of ulcer healing, safety, and efficacy. Meta-analysis suggests that concomitant treatment could significantly reduce ulcer recurrence rates, but included studies were subject to some biases and short follow-up. Concomitant treatment may be considered to prevent recurrence rather than improve ulcer healing.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Kiernan A, Fahey B, Boland F, et al. A systematic review and meta-analysis of concomitant truncal and perforator surgery. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36736858. doi:10.1016/j.jvsv.2022.12.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。